High throughput drug screening.
Heemskerk
Jill
J
National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D020650:Combinatorial Chemistry Techniques / Q000379:methods*; D003198:Computer Simulation; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004358:Drug Therapy; D006801:Humans; D009316:National Institutes of Health (U.S.); D009498:Neurotoxins / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000235:genetics; D000072105:Superoxide Dismutase-1; D014481:United States
D009498:Neurotoxins; C000606290:SOD1 protein, human; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1